Discover 1,171 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,171
Registry of Asthma Characterization and Recruitment 3 (RACR3)
for
Asthma
Location: Cincinnati OH, Chicago IL, Washington D.C. DC,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 0+
Code: NCT05272241
Recruiting
Infant Formula in Infants and Children With Cow's Milk Allergy
for
Cow's Milk Allergy
Location: Cincinnati OH, Columbus OH, Ann Arbor MI, Cleveland OH,
Sponsor: Abbott Nutrition
Sex: All
Age: 0 - 12
Code: NCT06456541
Recruiting
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
for
B-cell Acute Lymphoblastic Leukemia, Obesity
Location: Cincinnati OH, Ann Arbor MI, Chicago IL, Charlotte NC,
Sponsor: Etan Orgel
Sex: All
Age: 7 - 25
Code: NCT05082519
Phase2, Recruiting
Quality of Pediatric Resuscitation in a Multicenter Collaborative
for
Cardiac Arrest, Cardiopulmonary Arrest
Location: Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0 - 18
Code: NCT02708134
Recruiting
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
for
Amblyopia
Location: Cincinnati OH, Columbus OH, Bloomington IN,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 4 - 7
Code: NCT06380517
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Location: Cincinnati OH, Indianapolis IN, Ann Arbor MI,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT04851119
Phase1, Phase2, Recruiting
ADHD PreSMA Response Inhibition Therapy
for
Attention Deficit Hyperactivity Disorder
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 12 - 17
Code: NCT06325813
Recruiting
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
for
Recurrent or Refractory Solid Tumors, Ewing Sarcoma,
Location: Cincinnati OH, Milwaukee WI, Oklahoma City OK,
Sponsor: South Plains Oncology Consortium
Sex: All
Age: 1 - 20
Code: NCT02013336
Phase1, Recruiting
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
for
Juvenile Psoriatic Arthritis
Location: Cincinnati OH, Cleveland OH, Pittsburgh PA, Chicago IL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 2 - 17
Code: NCT06751238
Phase1, Recruiting
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
for
Cystic Fibrosis
Location: Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: Sonya Heltshe
Sex: All
Age: 0 - 10
Code: NCT04509050
Recruiting
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
for
Myeloid Leukemia, Philadelphia Positive
Location: Cincinnati OH, Indianapolis IN, Philadelphia PA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 1 - 17
Code: NCT04925479
Phase1, Phase2, Recruiting
Phenotypic and Genetic Assessment of Tracheal and Esophageal Birth Defects in Patients